Unlike its incompletely understood role in chemotherapy, KCa3.1 has consistently been demonstrated to exert pro-survival functions in ionizing radiation-treated T cell leukemia [27], lung adenocarcinoma [19], and glioblastoma [21,28]. The gene discussed is KCNN4; the disease is glioblastoma.